Source: Knowridge, February 2017

The United States Preventive Services Task Force has released a report saying there isn’t enough evidence to recommend that clinicians perform visual screening for melanomas for patients with no known risk for the skin cancer.

Two dermatology experts agree that the evidence doesn’t meet the task force’s standards—but question whether the standards are appropriate in the first place.

“If you were to take a poll among practicing dermatologists, you’d find the vast majority believe that early detection reduces risk of death from melanoma,” says Martin Weinstock, professor of dermatology in the Warren Alpert Medical School at Brown University.